Calprest Calprotectin Assay

Eurospital- CalPrestCalprest is an enzyme immunoassay developed by Eurospital to assess bowel inflammation with an accurate and non-invasive method.
Calprest is very helpful to differentiate organic Inflammatory Bowel Disease (IBD) and functional disorders like Irritable Bowel Syndrome (IBS). A negative Calprest results allows excluding almost certainly bowel inflammation.

The diagnostic application of Calprest is based on the quantitative measurement of calprotectin in stools: in patients with Inflammatory Bowel Disease the level of calprotectin in generally very high. Patients with Irritable Bowel Syndrome show substantially lower levels of calprotectin than in IBD; sometimes higher than the cut-off but always higher than in healthy subjects.
Calprest can therefore be used to select patients with inflammation to be submitted to further investigations in a more accurate way than the usual biochemical tests (ESR, CPR).


View additional information on Eurospital’s website >>

Home | About Us | Medical Division | Life Science Division | Our Partners | Careers | Newsroom | Legal Notice

All Rights reserved, Neopharm Group, Israel | Design by: VAZA | Developed by: The Shark Lady